Introduction
It is well known that cell-mediated immunity depression correlates well with the occurrence of local or systemic candida infection. ' (1990) (1991) (1992) 16 (19-0) 10 (1 1-9) 15 18 (21-4) 51 (60-7)
3 (2-6) 12 49 (58-3) derivatives, could have been responsible for the selection of nonalbicans strains through a pressure selection mechanism.14--6 Almost 60% of HIV-positive patients in this study reported a history of candida vaginitis in the year before the study and 30% of them had had recurrent infection treated mostly with imidazole derivatives. This may account for the high prevalence of non-albicans strains in the HIV-positive population. The high rate of Torulopsis glabrata or other non-albicans species as causal agents of recurrent vaginal infection in HIV-positive women should be taken into consideration from both the diagnostic and therapeutic viewpoint. In fact, the diagnosis of torulopsis vaginal infection on light microscopy may be difficult owing to the absence of hyphae and the characteristic spores. In addition, the infection is very difficult to eradicate since Torulopsis glabrata is usually less sensitive to the commonly used antimycotic agents, and resistance to the imidazole derivatives may also develop.'7 Boric acid used vaginally has also proven effective. '4 In conclusion, this study has shown that in HIV-seropositive patients, vulvovaginal candidiasis is very common and is correlated with the immunological status of the host. These patients had higher frequencies of Torulopsis glabrata vaginal infection and are more prone to recurrence than HIV-negative controls.
